what is a glp 1 medication Understanding GLP-1 medications GLP-1 Medications and Birth Control

Bakker MK, van Straten T, Chong M, Par G, Gill D, Ruigrok YM

Clinical Trials Demonstrating Reductions in Body Weight with GLP-1RAs Several clinical trials have reported that the effects described above resulted in larger reductions in body weight with GLP-1RA therapy compared with placebo in participants with obesity

Nearly 25% of the population in western countries have NAFLD and up to 6.5% fulfill the criteria of NASH ( NAFLD is considered the hepatic manifestation of metabolic syndrome ( No pharmacological therapies are approved for the treatment of NAFLD and lifestyle changes focusing on caloric restriction and weight loss constitute the general treatment recommendations

FIGURE 3 2.2.1 PINK1/Parkin-mediated mitophagy Under normal conditions, PINK1 (PTEN-induced kinase 1) is continuously degraded in healthy mitochondria

The researchers noted that some of the studys findings were imprecise, and that continuous monitoring and further research will provide more precise risk estimates

2016;310(1):G26-33